WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical enters into new and expanded distribution agreements with BioNuclear and Atlantic Medical International, respectively.
In the latest trading session, Rockwell Medical (RMTI) closed at $1.65, marking a +1.85% move from the previous day.
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical today announced that it has been certified as a Great Place to Work® for the second year in a row.
Rockwell Medical (RMTI) came out with quarterly earnings of $0.02 per share, beating the Zacks Consensus Estimate of a loss of $0.08 per share. This compares to loss of $0.20 per share a year ago.
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes
Rockwell Medical (RMTI) concluded the recent trading session at $1.54, signifying a +1.32% move from its prior day's close.
In the closing of the recent trading day, Rockwell Medical (RMTI) stood at $1.48, denoting a +0.68% change from the preceding trading day.
In the closing of the recent trading day, Rockwell Medical (RMTI) stood at $1.37, denoting no change from the preceding trading day.
In the closing of the recent trading day, Rockwell Medical (RMTI) stood at $1.34, denoting a -0.74% change from the preceding trading day.
Rockwell Medical (RMTI) closed at $1.29 in the latest trading session, marking no change from the prior day.
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will release its results for the fourth quarter and full-year ended December 31, 2023 on Thursday, March 21, 2024.
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Defers principal payments of $8M up to 3yrs, reduces Rockwell Medical's need for additional operating capital, and enhances the Company'
Rockwell Medical is arguably the strongest player in the hemodialysis market and a top 5 healthcare supplier per Seeking Alpha Quant. The Company still addresses a critical medical condition and has a
Rockwell Medical, Inc. (NASDAQ:RMTI ) Q3 2023 Earnings Conference Call November 14, 2023 8:00 AM ET Company Participants Heather Hunter - SVP & Chief Corporate Affairs Officer Mark Strobeck - Presiden
Rockwell Medical (RMTI) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to loss of $0.40 per share a year ago.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE